Mayne Pharma Group Limited announced that Dr. Carolyn Myers will retire from the Board at the end of July 2023.
Dr Myers has served as a Director of Mayne Pharma since October 2021. She was appointed to the
Board after being nominated by Mithra Pharmaceuticals SA under the terms of the license and
supply agreement to commercialise NEXTSTELLIS® (E4/DRSP) oral contraceptive in the United
States.